Moderna is planning another covid campaign starting April 2025

According to Endpoints News, covid vax business is in trouble - both Pfizer and Moderna are tanking, and heads of sales have departed:

[Moderna] reaffirmed its focus on driving Covid-19 and soon RSV vaccine sales, though the former’s sales have been challenged by waning demand. Moderna said last month that it expects Covid sales to “hit a low point” in 2024, while Pfizer recently slashed expectations for its Comirnaty shot by $2 billion.

Pfizer also announced an executive shake-up on Tuesday. Chief commercial officer and global biopharma president Angela Hwang will depart after 27 years at the pharma giant as the company creates two non-oncology commercial units.

Click to read more...